• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物制剂和小分子抑制剂治疗难治性脱发性滤泡炎的疗效。

Recalcitrant Folliculitis Decalvans Treatment Outcomes With Biologics and Small Molecule Inhibitors.

机构信息

Dr. Fakhoury is from Lake Erie College of Osteopathic Medicine, Bradenton, Florida. Dr. Urban is from Prime West Consortium, Newport Beach, California. Drs. Ettefagh and Nami are from Island Dermatology, Newport Beach.

出版信息

Cutis. 2024 May;113(5):E32-E34. doi: 10.12788/cutis.1023.

DOI:10.12788/cutis.1023
PMID:39042121
Abstract

Folliculitis decalvans (FD) is a rare primary neutrophilic cicatricial alopecia that commonly displays resistance to traditional therapies and remains challenging to treat. Currently, data are lacking with recommendations for therapy-recalcitrant FD. A systematic review was conducted to analyze biologics, small molecule inhibitors, tumor necrosis factor (TNF) inhibitors, Janus kinase (JAK) inhibitors, phosphodiesterase 4 (PDE4) inhibitors, and monoclonal antibodies utilized in the treatment of recalcitrant FD.

摘要

脱发性毛囊炎(FD)是一种罕见的原发性嗜中性瘢痕性脱发,通常对传统疗法有抵抗力,治疗仍然具有挑战性。目前,对于难治性 FD 的治疗建议缺乏数据。进行了系统评价,以分析生物制剂、小分子抑制剂、肿瘤坏死因子(TNF)抑制剂、Janus 激酶(JAK)抑制剂、磷酸二酯酶 4(PDE4)抑制剂和用于治疗难治性 FD 的单克隆抗体。

相似文献

1
Recalcitrant Folliculitis Decalvans Treatment Outcomes With Biologics and Small Molecule Inhibitors.生物制剂和小分子抑制剂治疗难治性脱发性滤泡炎的疗效。
Cutis. 2024 May;113(5):E32-E34. doi: 10.12788/cutis.1023.
2
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors.成人斑秃治疗新药的系统评价:Janus 激酶抑制剂、生物制剂和磷酸二酯酶 4 抑制剂。
J Eur Acad Dermatol Venereol. 2023 Apr;37(4):666-679. doi: 10.1111/jdv.18810. Epub 2022 Dec 22.
3
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.生物制剂或托法替布用于对甲氨蝶呤或其他传统改善病情抗风湿药物反应不完全的类风湿关节炎患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2016 May 13;2016(5):CD012183. doi: 10.1002/14651858.CD012183.
4
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.生物制剂或托法替布用于初治类风湿关节炎患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 May 8;5(5):CD012657. doi: 10.1002/14651858.CD012657.
5
Systematic review of comparative studies on emerging psoriasis treatments: comparing biologics with biologics, small molecule inhibitors with small molecule inhibitors, and biologics with small molecule inhibitors.新兴银屑病治疗方法比较研究的系统评价:生物制剂与生物制剂、小分子抑制剂与小分子抑制剂以及生物制剂与小分子抑制剂的比较
Inflammopharmacology. 2025 May 29. doi: 10.1007/s10787-025-01758-2.
6
Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta-analysis.口服 JAK 抑制剂和生物制剂治疗成人斑秃的疗效比较:系统评价和贝叶斯网络荟萃分析。
J Eur Acad Dermatol Venereol. 2024 May;38(5):835-843. doi: 10.1111/jdv.19797. Epub 2024 Jan 26.
7
Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review.生物制剂和 Janus 激酶(JAK)抑制剂在瘢痕性脱发中的超说明书用药:一项叙述性综述。
Arch Dermatol Res. 2025 Jun 9;317(1):803. doi: 10.1007/s00403-025-04301-z.
8
The impact of biological interventions for ulcerative colitis on health-related quality of life.溃疡性结肠炎生物干预措施对健康相关生活质量的影响。
Cochrane Database Syst Rev. 2015 Sep 22;2015(9):CD008655. doi: 10.1002/14651858.CD008655.pub3.
9
Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis.Janus 激酶抑制剂治疗斑秃:系统评价和荟萃分析。
JAMA Netw Open. 2023 Jun 1;6(6):e2320351. doi: 10.1001/jamanetworkopen.2023.20351.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.